Plasmodium vivax is the most widespread cause of malaria with a high burden of disease. Progress in reducing the global malaria burden has stalled with no vaccines available partly due to a limited knowledge of targets and mechanisms of protective immunity. We developed a platform to quantify antibody functions to multiple P. vivax antigens and dissect immunity in a longitudinal cohort of children from Papua New Guinea at risk of P. vivax malaria. We identified antigens targeted by multiple functional antibodies, including interactions with Fcγ receptors, which mediate different cellular effector functions, and complement fixation, advancing our understanding of P. vivax immunity. We identified specific antigens targeted by antibodies associated with protection from P. vivax malaria. Evaluating thousands of possible combinations, we identified subsets of antigens in the most protective combinations providing leads for developing highly protective multi-antigen P. vivax vaccines eliciting multi-functional antibody responses to achieve and sustain elimination.
Building similarity graph...
Analyzing shared references across papers
Loading...
D. Herbert Opi
Rhea J. Longley
Eizo Takashima
Immunity
Walter and Eliza Hall Institute of Medical Research
Ehime University
Burnet Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Opi et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69a528b3f1e85e5c73bf0331 — DOI: https://doi.org/10.1016/j.immuni.2026.02.003
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: